Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 271
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
The Problems We Will Be Lucky to Have
Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
Is It Worth It? What Colorado’s Early Experience With Regulated Psychedelic Care Has the Field Asking, and What To Do About It
Compass Says NDA Will Be Filed Within Two Weeks, Declines to Comment on Usona
Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA, and FDA Approves NRx’s Generic Ketamine
PT248 – Pierre Bouchard – Somatic Therapy, Trauma, and the Nervous...
Psychedelic Research Bulletin: May 2021
Psychedelic Bulletin: MindMed CEO Steps Down; Atai Targets $2.3bn Valuation
Filament Announces First GMP Batch of Pharmaceutical Grade Natural Psilocybin
PTSF63 – The Media and Legalization, Joints for Jabs, and 40,000...
Atai Targets $2.3bn Valuation in Nasdaq IPO
atai Life Sciences Announces Launch of Initial Public Offering
LSD and the Anarchic Brain
Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit...
Red Light Holland Closes Acquisition of 80% of Happy Caps Mushroom...
Load more